News

Selections from weekend health care coverage, August 17, 2020.

U.S. healthcare was gearing up for a rebound that includes telehealth. But then the pandemic surged back.

Yale-developed, NBA-funded saliva test costing $10 per test could make frequent testing of asymptomatic people feasible.

Actions from FDA this week include approval of a second targted treatment for a Duchenne muscular dystrophy mutation, and filings in COVID-19 and blood disorders.

In this part two of two series, Senior Editor Peter Wehrwein and Associate Editor Briana Contreras chat with Keely Macmillan, senior vice president of policy and solutions management at Archway Health. The trio discusses the Value in Health Care Act of 2020, which would make some important changes to the Medicare Shared Savings Programs ACOs, the largest CMS ACO program.

In this part one of two series, Senior Editor Peter Wehrwein and Associate Editor Briana Contreras chat with Keely Macmillan, senior vice president of policy and solutions management at Archway Health. The trio discusses the Value in Health Care Act of 2020, which would make some important changes to the Medicare Shared Savings Programs ACOs, the largest CMS ACO program.

Deloitte, a consulting firm, recently released new data on consumer behaviors towards healthcare and how those behaviors changed as a result of the COVID-19 pandemic in a survey.

The physician-led communication training program is now available through a virtual-only experience as health care organizations adapt to the changing environment surrounding COVID-19.

A majority of executives believe technology has become an inseparable part of the human experience in a recent survey. However, a bit more than half of those execs said advancements in new technologies and scientific innovations are positioned to disrupt the industry.

Dr. Karen Vloedman shares her learnings that will help inform best practices to assist payers and provider groups when preparing for and navigating the CoVID-19 pandemic.

In this week's episode, Briana Contreras spoke with Suzet McKinney, CEO of the Illinois Medical District and an Adjunct Instructor at Harvard University's T.H. Chan School of Public Health. The two discussed the role of social determinants when promoting health and health equity and most importantly why and how racism is a public health issue.

Harris ended up proposing a moderate Medicare for all plan modeled on the Medicare Advantage choice that seniors now have.

Physical therapy or the regular physical activity that successful treatment of MSK disorders makes possible helps reduce the risk of many chronic conditions including type 2 diabetes, heart disease and hypertension, dementia, and mental health issues like depression and anxiety.

Colcrys and Copaxone are among the exceptions.

Evrysdi is only the second drug approved to treat the rare disease.

Botco.ai’s AI-powered intelligent chat solution automatically addresses questions regarding COVID-19, scheduling visits, franchising and more.

Olinvyk is the first new chemical entity in this IV drug class in decades.

Researchers reviewed the evidence of the association between vitamin D and multiple sclerosis.

A recent study found 64% of patients with psoriatic arthritis who had tried at least one biologic stayed with Cosentyx for the entire study period.

Next generation PBMs like Flipt and RxSense are challenging the "old guard" PBMs that control three-quarters of the market.

Adaptive Biotechnologies’ clonoSEQ gets third approval; FDA also acts on first at-home treatment for spinal muscular atrophy.

In this part two of two video series Adam Block discusses his recent article, “Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates.”

Dovato lets adults with HIV reduce the number of antiretroviral therapies they take, while maintaining efficacy and a high barrier to resistance comparable to tenofovir-based regimens.

In this part one of two video series, Adam Block, a New York Medical College assistant professor, discusses his recent contributed article to Managed Healthcare Executive titled "Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates."

Double-blind study will compare Rebif-remdesivir combination with remdesivir-alone in hospitalized COVID-19 patients

The highly respected healthcare industry veteran will bring his signature team building skills, track record of double-digit revenue growth and subject matter expertise in diabetes.

In this part two of two series, Carolyn Langer, M.D., Fallon Health's chief medical officer, talks about Collective Medical and the advantages of real-time notifications of member hospital admissions and discharges and emergency department visits.